\-\ Texto\\:\\ \ \(0\)\
\-\ csf\\ studies\\ positive\\ for\\ multiple\\ sclerosis\ \(0\)\
\-\ surgical\\ removal\\ of\\ third\\ ventricular\\ mass\ \(0\)\
\-\ \\â\\€\\¢\\ non\\-enhancing\\ third\\ ventricular\\ mass\ \(0\)\
\-\ \\â\\€\\¢\\ secondary\\ obstructive\\ hydrocephalus\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ supra\\-\\ and\\ infra\\-tentorial\\ lesions\\ and\\ spinal\\ cord\\ lesions\\ consistent\\ with\\ demyelinating\\ plaques\\ \\-\\ some\\ lesions\\ enhance\\,\\ consistent\\ with\\ active\\ ms\\.\ \(0\)\
\-\ neurocytoma\\ 3rd\\ ventricle\\,\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ oligodendroglioma\ \(1\)\
\-\ \\â\\€\\¢\\ central\\ neurocytoma\ \(2\)\
\-\ \\â\\€\\¢\\ ependymoma\\,\\ subependymoma\ \(0\)\
\-\ \\â\\€\\¢\\ adem\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 35\\ year\\ old\\ woman\\ presents\\ to\\ er\\ with\\ bilateral\\ lower\\ extremity\\ weakness\\ and\\ numbness\\.\\ \\ has\\ recently\\ been\\ diagnosed\\ with\\ multiple\\ sclerosis\\ by\\ neurologist\\.\ \(0\)\
\-\ neurocytomas\\ are\\ typically\\ seen\\ in\\ a\\ lateral\\ ventricular\\ location\\,\\ arising\\ from\\ the\\ septum\\ pellucidum\\.\\ \\ third\\ ventricular\\ tumors\\,\\ like\\ this\\ one\\,\\ are\\ less\\ frequent\\.\\ \\ \ \(0\)\
\-\ the\\ coincidental\\ diagnosis\\ of\\ a\\ primary\\ brain\\ neoplasm\\ in\\ patient\\ with\\ ms\\ is\\ also\\ quite\\ unusual\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ventricular\\:\\ 0\\.11313499704303358\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.09286010972420077\ \(0\)\
\-\ neurocytoma\\:\\ 0\\.08021216358969396\ \(0\)\
\-\ third\\:\\ 0\\.07614325986999994\ \(0\)\
\-\ sclerosis\\:\\ 0\\.06820700518725212\ \(0\)\
\-\ ms\\:\\ 0\\.06765960269506872\ \(0\)\
\-\ supra\\-\\:\\ 0\\.06530013647382592\ \(0\)\
\-\ infra\\-tentorial\\:\\ 0\\.06530013647382592\ \(0\)\
\-\ neurocytomas\\:\\ 0\\.06530013647382592\ \(0\)\
\-\ coincidental\\:\\ 0\\.053378374159499246\ \(0\)\
\-\ multiple\\:\\ 0\\.05332758528827464\ \(0\)\
\-\ lesions\\:\\ 0\\.050834677918754394\ \(0\)\
\-\ subependymoma\\:\\ 0\\.04476244223501272\ \(0\)\
\-\ neurologist\\:\\ 0\\.044313370962298385\ \(0\)\
\-\ pellucidum\\:\\ 0\\.04010608179484698\ \(0\)\
\-\ demyelinating\\:\\ 0\\.03917894740259509\ \(0\)\
\-\ non\\-enhancing\\:\\ 0\\.03855259638016499\ \(0\)\
\-\ adem\\:\\ 0\\.038162642798791495\ \(0\)\
\-\ quite\\:\\ 0\\.038162642798791495\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.037102636549601324\ \(0\)\
\-\ plaques\\:\\ 0\\.03535160856394036\ \(0\)\
\-\ obstructive\\:\\ 0\\.032567983823480744\ \(0\)\
\-\ septum\\:\\ 0\\.03239160864797172\ \(0\)\
\-\ frequent\\:\\ 0\\.031646101049603664\ \(0\)\
\-\ 3rd\\:\\ 0\\.03133741440959945\ \(0\)\
\-\ consistent\\:\\ 0\\.031041455834536345\ \(0\)\
\-\ enhance\\:\\ 0\\.030617682939572434\ \(0\)\
\-\ unusual\\:\\ 0\\.030617682939572434\ \(0\)\
\-\ numbness\\:\\ 0\\.030414727575216034\ \(0\)\
\-\ recently\\:\\ 0\\.029534849530845907\ \(0\)\
\-\ like\\:\\ 0\\.02930152607114686\ \(0\)\
\-\ 35\\:\\ 0\\.0291312333435565\ \(0\)\
\-\ ependymoma\\:\\ 0\\.02833396916435379\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.027213739758991395\ \(0\)\
\-\ csf\\:\\ 0\\.02643329149485935\ \(0\)\
\-\ arising\\:\\ 0\\.026202990849896156\ \(0\)\
\-\ removal\\:\\ 0\\.024953933720742134\ \(0\)\
\-\ er\\:\\ 0\\.02428284560702194\ \(0\)\
\-\ active\\:\\ 0\\.02416710251144356\ \(0\)\
\-\ cord\\:\\ 0\\.024053140149669642\ \(0\)\
\-\ tumors\\:\\ 0\\.023775676723485194\ \(0\)\
\-\ ventricle\\:\\ 0\\.023721409759840207\ \(0\)\
\-\ studies\\:\\ 0\\.02364074753910489\ \(0\)\
\-\ weakness\\:\\ 0\\.0235082322446547\ \(0\)\
\-\ diagnosed\\:\\ 0\\.023275519679963004\ \(0\)\
\-\ extremity\\:\\ 0\\.023149325701055094\ \(0\)\
\-\ spinal\\:\\ 0\\.02266500896577471\ \(0\)\
\-\ typically\\:\\ 0\\.022343894588933128\ \(0\)\
\-\ location\\:\\ 0\\.022079316199288098\ \(0\)\
\-\ neoplasm\\:\\ 0\\.021556715377125394\ \(0\)\
\-\ less\\:\\ 0\\.021436592624612463\ \(0\)\
\-\ central\\:\\ 0\\.020826898939703402\ \(0\)\
\-\ positive\\:\\ 0\\.02053989326136383\ \(0\)\
\-\ some\\:\\ 0\\.0192216907693834\ \(0\)\
\-\ brain\\:\\ 0\\.0190470483207612\ \(0\)\
\-\ primary\\:\\ 0\\.018750994539968122\ \(0\)\
\-\ secondary\\:\\ 0\\.017696518270435613\ \(0\)\
\-\ mass\\:\\ 0\\.017606829732556513\ \(0\)\
\-\ are\\:\\ 0\\.01725739070414225\ \(0\)\
\-\ been\\:\\ 0\\.017220702884918452\ \(0\)\
\-\ one\\:\\ 0\\.01715356580230107\ \(0\)\
\-\ metastatic\\:\\ 0\\.01593414373048956\ \(0\)\
\-\ bilateral\\:\\ 0\\.015361612809736623\ \(0\)\
\-\ woman\\:\\ 0\\.01462150331473264\ \(0\)\
\-\ diagnosis\\:\\ 0\\.014534958005780889\ \(0\)\
\-\ lower\\:\\ 0\\.014236015328621204\ \(0\)\
\-\ lateral\\:\\ 0\\.013679022560181855\ \(0\)\
\-\ \\-\\:\\ 0\\.013568358953395285\ \(0\)\
\-\ surgical\\:\\ 0\\.013305346446307063\ \(0\)\
\-\ presents\\:\\ 0\\.012930698485243896\ \(0\)\
\-\ seen\\:\\ 0\\.012508352704205113\ \(0\)\
\-\ also\\:\\ 0\\.012478663656815936\ \(0\)\
\-\ \\,\\:\\ 0\\.012031558467434995\ \(0\)\
\-\ has\\:\\ 0\\.011886666448105763\ \(0\)\
\-\ by\\:\\ 0\\.010539784468480555\ \(0\)\
\-\ disease\\:\\ 0\\.010346204009005216\ \(0\)\
\-\ from\\:\\ 0\\.009381005282623795\ \(0\)\
\-\ this\\:\\ 0\\.0071195349134380225\ \(0\)\
\-\ year\\:\\ 0\\.0070822612538734425\ \(0\)\
\-\ old\\:\\ 0\\.006480997013794479\ \(0\)\
\-\ patient\\:\\ 0\\.006345125414195467\ \(0\)\
\-\ in\\:\\ 0\\.006242921928003777\ \(0\)\
\-\ a\\:\\ 0\\.005875552619534834\ \(0\)\
\-\ for\\:\\ 0\\.005400801101057149\ \(0\)\
\-\ with\\:\\ 0\\.004333488003329249\ \(0\)\
\-\ is\\:\\ 0\\.004165116876923894\ \(0\)\
\-\ and\\:\\ 0\\.004000200127382633\ \(0\)\
\-\ to\\:\\ 0\\.0031634674699480463\ \(0\)\
\-\ the\\:\\ 0\\.0020481375511648267\ \(0\)\
\-\ of\\:\\ 0\\.0017259822340442731\ \(0\)\
\-\ \\.\\:\\ 0\\.0015777571598820568\ \(0\)\
